Skip to main content

Greenberg Traurig Dallas Attorneys Named to D CEO’s 2027 Dallas 500

DALLAS – Nov. 11, 2026– Shareholders Joseph F. Coniglio and Bina Palnitkar from global law firm Greenberg Traurig, LLP’s Dallas office have been selected to D CEO’s 2027 Dallas 500 list.

According to the publication, Dallas 500 profiles influential leaders across a wide range of industries in North Texas. The list is developed through months of research, interviews, and conversations with high-level contacts throughout the region’s business community.

“Joe and Bina bring exceptional experience, leadership, and commitment to our clients and the Dallas community,” Texas Co-Regional Operating Shareholders Shari L. Heyen and Demetrius G. McDaniel said in a joint statement. “Their recognition by D CEO reflects the meaningful contributions they continue to make in their respective practices and throughout North Texas. We are proud to see these two included among this year’s Dallas 500 honorees.”

Coniglio is a Texas Co-Regional Operating Shareholder and is the managing shareholder of the firm’s Dallas office. With more than 20 years of experience in the health care industry, he advises health care entities and providers, including hospitals, physician groups, long-term care facilities, clinical laboratories, and pharmacies, on litigation and transactional matters. He also represents privately held portfolio companies and publicly traded companies in corporate entity issues, operational disputes, and health care regulatory matters.

Palnitkar serves as Co-Chair of the firm’s Texas Litigation Practice and represents family offices, private equity firms, institutional investors, and companies in complex business and litigation matters. Her practice spans mergers and acquisitions, real estate, fund formation, aviation, employment matters, high-stakes commercial litigation, and cross-border intellectual property enforcement. She also advises clients on anti-counterfeiting and brand protection matters and serves as national settlement counsel for two global medical device companies, managing complex nationwide settlements and developing strategies aligned with clients’ business objectives.

View the full list of honorees.